Agitation Associated With Alzheimer's Disease Dementia trials recruiting in New York

Fewer than 3 recruiting trials found.

All Agitation Associated With Alzheimer's Disease Dementia trials nationally

Cities in New York

Recruiting trials in New York

• Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
  NCT07284472 · Phase: Phase 2, Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · New York: Brooklyn, New York